DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.99
-0.53 (-2.46%)
At close: Feb 27, 2026, 4:00 PM EST
20.58
-0.41 (-1.95%)
After-hours: Feb 27, 2026, 7:32 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Conducting of Research and Development of Epicutaneous Immunotherapy Products | 4.15M | 15.73M | 4.84M | 5.71M | 11.28M | | | | | |
Conducting of Research and Development of Epicutaneous Immunotherapy Products Growth | -73.61% | 224.69% | -15.14% | -49.38% | -23.33% | | | | | |
| 4.15M | 15.73M | 4.84M | 5.71M | 11.28M | | | | | |
| -73.61% | 224.69% | -15.14% | -49.38% | -23.33% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 4.15M | 15.73M | 4.84M | 5.71M | 11.28M | | | | | |
| -73.61% | 224.69% | -15.14% | -49.38% | -23.33% | | | | | |
| 4.15M | 15.73M | 4.84M | 5.71M | 11.28M | | | | | |
| -73.61% | 224.69% | -15.14% | -49.38% | -23.33% | | | | | |
Source: S&P Global Market Intelligence.
